Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
110.99
+2.02 (+1.85%)
Streaming Delayed Price
Updated: 3:01 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
245,870
Open
108.85
Bid (Size)
110.91 (6)
Ask (Size)
111.06 (6)
Prev. Close
108.97
Today's Range
108.35 - 111.25
52wk Range
76.53 - 131.49
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioNTech Se (BNTX) Q3 2024 Earnings Call Transcript
November 04, 2024
BNTX earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
November 04, 2024
BioNTech's Q3 revenue surged to €1.244 billion, reflecting early COVID-19 vaccine approvals. Net profit rose to €198.1 million, and full-year guidance adjusted downward.
Via
Benzinga
Exposures
COVID-19
Performance
YTD
-1.21%
-1.21%
1 Month
-8.69%
-8.69%
3 Month
+41.64%
+41.64%
6 Month
+18.90%
+18.90%
1 Year
+11.31%
+11.31%
More News
Read More
BioNTech Jumps On Surprise Profit, Wide Sales Beat; But Lowers Outlook
November 04, 2024
Via
Investor's Business Daily
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
November 04, 2024
From
BioNTech SE
Via
GlobeNewswire
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
November 01, 2024
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Forecasting The Future: 15 Analyst Projections For BioNTech
October 07, 2024
Via
Benzinga
BioNTech to Host Innovation Series R&D Day on November 14, 2024
October 31, 2024
From
BioNTech SE
Via
GlobeNewswire
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
October 24, 2024
Via
The Motley Fool
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
October 21, 2024
Via
Benzinga
Exposures
Product Safety
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
October 21, 2024
From
BioNTech SE
Via
GlobeNewswire
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
October 17, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
October 15, 2024
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake
October 07, 2024
Via
Investor's Business Daily
4 Reasons Pfizer Could Be a Value Play You Can't Miss
October 07, 2024
Via
MarketBeat
Exposures
COVID-19
Product Safety
Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday
October 07, 2024
Via
Benzinga
Consumer Tech News (Sept 30-Oct 4): Latest Windows 11 Update Causing Trouble, Apple Accused Of Compelling Employees To Sign Illegal Agreements & More
October 06, 2024
Via
Benzinga
Topics
Artificial Intelligence
Law Enforcement
Exposures
Artificial Intelligence
Legal
Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
October 02, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
October 01, 2024
From
BioNTech SE
Via
GlobeNewswire
Exxon Mobil To $120? Here Are 10 Top Analyst Forecasts For Tuesday
September 24, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024
From
BioNTech SE
Via
GlobeNewswire
How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery
September 17, 2024
Via
Investor's Business Daily
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
September 17, 2024
From
BioNTech SE
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
